Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.730
-0.011 (-1.46%)
At close: Dec 5, 2025, 4:00 PM EST
0.730
-0.000 (-0.03%)
After-hours: Dec 5, 2025, 7:38 PM EST
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $38.34 million as of December 5, 2025. Its market cap has decreased by -10.31% in one year.
Market Cap
38.34M
Enterprise Value
-58.17M
1-Year Change
-10.31%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $38.34M, a decrease of -91.02%. That is a compound annual growth rate of -44.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 38.90M | -7.33% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |